[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365829-105":59,"doc-detail-365829-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tcf19-expression-and-significance-analysis-in-breast-cancer-integrated-bioinformatics-analysis-and-histological-validation","TCF19 expression and significance analysis in breast cancer: integrated bioinformatics analysis and histological validation","","Transcription factor 19 (TCF19) is part of the transcription factor family, yet its function in cancer remains insufficiently defined. This study combines bioinformatics analysis with histological validation to clarify TCF19 roles across cancers, with emphasis on breast cancer, and to determine mechanistic links. Analyses integrate gene expression profiles and clinical data, followed by experimental confirmation. Findings position TCF19 as a clinically relevant marker with diagnostic and prognostic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tcf19-expression-and-significance-analysis-in-breast-cancer-integrated-bioinformatics-analysis-and-histological-validation/365829/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tcf19-expression-and-significance-analysis-in-breast-cancer-integrated-bioinformatics-analysis-and-histological-validation/365829.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this study on TCF19 in breast cancer?","Question",{"text":112,"@type":113},"The study clarifies the role of TCF19 in breast cancer and explores its mechanisms using integrated bioinformatics analysis and histological validation, including clinical specimens and experimental confirmation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was TCF19 expression validated experimentally?",{"text":117,"@type":113},"TCF19 expression was confirmed using quantitative RT-PCR, immunohistochemistry (IHC), and western blot, with additional functional validation assays such as CCK-8, colony formation, transwell, and cell line-derived xenografts.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship was found between TCF19 and patient outcomes and pathways?",{"text":121,"@type":113},"TCF19 is upregulated in multiple cancers including breast cancer, and higher levels correlate with poorer prognosis. Pathway enrichment links TCF19 to the PLK1 pathway, supported by reduced PLK1 after TCF19 silencing.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365829,1790269529,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Research  \nTCF19 expression and significance analysis in breast cancer: integrated bioinformatics analysis and histological validation  \nHaiyang Yu1 · Jingjing Wei2 · Qinhao Chen3 · Yueyin Pan1 · Xiaojun Qian1 · Jing Pan1,4 · Yubei Sun1  \nReceived: 22 July 2024 / Accepted: 2 May 2025  \n© The Author(s) 2025 OPEN  \nAbstract  \nBackground Transcription factor 19 (TCF19) is an important member of the transcription factor family, but its role in cancer is not well understood. This study aims to clarify the function ofTCF19 and explore its mechanisms across various cancers, with a specific focus on breast cancer, using bioinformatics analysis and histological validation.  \nMethods Gene expression profiles and clinical data were obtained from sources like The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and Genotype-Tissue Expression (GTEx) for bioinformatics analysis. Tumor–immune interactions were studied using theTISIDB database for immune-related insights. To confirm these findings, TCF19 expression was measured using quantitative RT-PCR, immunohistochemistry (IHC), and western blot assays. Additional validation was done with various experimental techniques, including CCK-8, colony-forming, transwell, and cell line-derived xenograft assays.  \nResults TCF19 is significantly upregulated in many cancerous tissues, including breast cancer, as confirmed across multiple datasets and clinical samples. Higher TCF19 levels were associated with a poorer prognosis. Experimentally reducing TCF19 expression in MCF-7 cells impaired key cellular functions such as proliferation, invasion, migration, and tumor formation. Pathway enrichment analysis of TCGA samples revealed a strong link between TCF19 and the PLK1 pathway, a finding further supported by western blot results showing PLK1 downregulation following TCF19 silencing. Conclusions High TCF19 expression is closely linked to poorer outcomes, especially in breast cancer. These findings highlight TCF19 as a promising biomarker with broad potential applications in cancer diagnosis and prognosis.  \nKeywords BRCA · Prognosis · TCF19 · PLK1 · Proliferation  \nHaiyang Yu, Jingjing Wei and Qinhao Chen contributed equally to this work.  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-025-](https://doi.org/10.1007/s12672-025-)[ ](https://doi.org/10.1007/s12672-025-)[02546-8](02546-8.)[.](02546-8.)  \n* Jing Pan, [jingpandoc@126.com](jingpandoc@126.com); * Yubei Sun, [sunyubei@ustc.edu.cn |](sunyubei@ustc.edu.cn |1Department of Oncology)[1](sunyubei@ustc.edu.cn |1Department of Oncology)[Department of Oncology](sunyubei@ustc.edu.cn |1Department of Oncology), The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. 2Department of Pathology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China. 3Department of Electrocardiogram, The 901st Hospital of the Joint Logistics Support Force of the Chinese People’s Liberation Army, Hefei, China. 4Hefei: Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China.  \nDiscover Oncology  \n(2025) 16:1047  \n| [https://doi.org/10.1007/s12672-025-02546-8](https://doi.org/10.1007/s12672-025-02546-8)  \n1 Introduction  \nCancer is a life-threatening disease that results from complex physiological and pathological processes. It imposes significant physical and emotional burdens on patients and families and adds economic and social strain [1] . The lack of accurate molecular markers for early diagnosis and prognosis contributes to high mortality, especially in less developed countries [2]. Breast cancer (BRCA) has now overtaken lung cancer as the most common malignancy worldwide, representing one-fourth of cancer cases and one-sixth of cancer-related deaths among women. Its incidence is widespread, with mortality rates higher than other cancers in half of the affected cou","cbCaiilwLHGOZM8G","https://ap.wps.com/l/cbCaiilwLHGOZM8G","pdf",5873039,15,"English","# 1 Introduction\n## Background and clinical need\n## Previous evidence on TCF19\n## Study objective","[{\"question\":\"What is the main purpose of this study on TCF19 in breast cancer?\",\"answer\":\"The study clarifies the role of TCF19 in breast cancer and explores its mechanisms using integrated bioinformatics analysis and histological validation, including clinical specimens and experimental confirmation.\"},{\"question\":\"How was TCF19 expression validated experimentally?\",\"answer\":\"TCF19 expression was confirmed using quantitative RT-PCR, immunohistochemistry (IHC), and western blot, with additional functional validation assays such as CCK-8, colony formation, transwell, and cell line-derived xenografts.\"},{\"question\":\"What relationship was found between TCF19 and patient outcomes and pathways?\",\"answer\":\"TCF19 is upregulated in multiple cancers including breast cancer, and higher levels correlate with poorer prognosis. Pathway enrichment links TCF19 to the PLK1 pathway, supported by reduced PLK1 after TCF19 silencing.\"}]","TCF19 expression and significance analysis in breast cancer: integrated bioinformatics analysis and histological validation | PDF",1790162549,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c635ad7d849d1071fd0bf80b027f862.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f4a71acdb6e53b47d347ea6eadfb6a4.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d188c0f8609e83f30ff6e47dcdae28d.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34e76c9430f5bcec176a87beb288bd73.webp",980,1301]